Title:
選択的に置換されたキノリン化合物
Document Type and Number:
Japanese Patent JP6420878
Kind Code:
B2
Abstract:
Embodiments of the disclosure relate to selectively substituted quinoline compounds that act as antagonists or inhibitors for Toll-like receptors 7 and/or 8, and their use in pharmaceutical compositions effective for treatment of systemic lupus erythematosus (SLE) and lupus nephritis.
Inventors:
Carlson, Eric
Hansen, Hans
Mackey, matthew
Schiller, Shawn
Ogawa, Chikako
Davis, Heather
Pea, Atsushi
Hawkins, Lynn
Sari, sari
Hansen, Hans
Mackey, matthew
Schiller, Shawn
Ogawa, Chikako
Davis, Heather
Pea, Atsushi
Hawkins, Lynn
Sari, sari
Application Number:
JP2017193598A
Publication Date:
November 07, 2018
Filing Date:
October 03, 2017
Export Citation:
Assignee:
Eisai R & D Management Co., Ltd.
International Classes:
C07D413/04; C07D413/14; C07D417/14; C07D451/04
Domestic Patent References:
| JP6223563B2 | ||||
| JP2013028588A | ||||
| JP2005132834A | ||||
| JP2007524615A | ||||
| JP2000510865A |
Foreign References:
| CN1528748A |
Other References:
Joint Bone Spine,2010年,Vol.77, No.1,pp.4-5,ISSN:1297-319X, DOI:10.1016/j.jbspin.2009.09.007
Attorney, Agent or Firm:
Yoshiyuki Inaba
Toshifumi Onuki
Akihiko Eguchi
Kazuhiko Naito
Toshifumi Onuki
Akihiko Eguchi
Kazuhiko Naito